Expert Pitch

NYC Board-Certified Dermatologist: Minority Communities Impacted by COVID-19 Experienced Surge in Temporary Hair Loss

American Academy of Dermatology

While the COVID-19 pandemic has had a profound impact on all of us, the extreme emotional stress brought on by lost jobs, loneliness from sheltering-in-place, and death of loved ones has disproportionately affected minority communities heavily impacted by COVID-19. New research in the Journal of the American Academy of Dermatology found an abrupt uptick in cases of telogen effluvium, or hair shedding, in low-income, racially diverse neighborhoods in New York City that experienced some of the highest COVID-19 death rates.

Board-certified dermatologists treating patients out of two safety-net hospitals in Brooklyn and Manhattan noticed a 400% increase in cases of hair shedding in people of color approximately three to four months after the shelter-in-place directive in NYC. The timing of the hair shedding correlates to when dermatologists would expect its onset following extreme physiological or emotional stress.

“The surge in cases of hair loss we are treating now is a delayed consequence of the illness and anxiety experienced by these predominantly minority communities during the first wave of COVID-19 in NYC,” said board-certified dermatologist Shoshana Marmon, MD, PhD, FAAD, assistant clinical professor, department of dermatology, New York Medical College, New York City. “Although this condition is usually temporary and gradually resolves on its own, hair loss is one of the most commonly reported complaints among ‘long-haulers’, or people with persistent symptoms following a COVID-19 infection. So it’s important that we follow these patients, in particular, to see if what they are experiencing is in fact temporary hair shedding or something related to ongoing illness or inflammation.”

Hair shedding happens when more hairs than normal enter the shedding (telogen) phase of the hair growth lifecycle. Fever, illness, post-pregnancy and extreme stress are among the conditions that can force more hairs than normal into the shedding phase.

Dr. Marmon is available to provide additional insights on this research and discuss hair loss, what people should know, and what they can do about it. She is a board-certified dermatologist and assistant clinical professor of dermatology with appointments in the Mount Sinai and New York Medical College dermatology departments. She is chief of dermatology at Woodhull and Cumberland Medical Centers in Brooklyn, New York.

The American Academy of Dermatology has resources available to the public that provide additional information about temporary hair loss and hair shedding:


Filters close

Showing results

110 of 5391
Released: 13-Apr-2021 4:05 PM EDT
B.1.1.7. variant more transmissible, does not increase severity, Lancet studies suggest

An observational study of patients in London hospitals suggests that the B.1.1.7. variant is not associated with more severe illness and death, but appears to lead to higher viral load, consistent with emerging evidence that this lineage is more transmissible than the original COVID-19 strain.

Newswise: Plasma device designed for consumers can quickly disinfect surfaces
Released: 13-Apr-2021 3:05 PM EDT
Plasma device designed for consumers can quickly disinfect surfaces
Princeton Plasma Physics Laboratory

The COVID-19 pandemic has cast a harsh light on the urgent need for quick and easy techniques to sanitize and disinfect everyday high-touch objects such as doorknobs, pens, pencils, and personal protective gear worn to keep infections from spreading.

Newswise: Narratives Can Help Science Counter Misinformation on Vaccines
Released: 13-Apr-2021 12:50 PM EDT
Narratives Can Help Science Counter Misinformation on Vaccines
Iowa State University

Narratives are a powerful tool that can help explain complex issues, but they can also serve as sources of misinformation, which presents a challenge as public health agencies work to educate people about COVID-19 vaccine.

Released: 13-Apr-2021 10:05 AM EDT
Puerto Rico, Coronavirus Among Top Latino Twitter Topics During 2020 Election
George Washington University

Latinos discussed Puerto Rico and the COVID-19 pandemic more than any other subject on Twitter in the run-up to the 2020 election, according to researchers at the George Washington University. Spanish-language tweets mentioning “freedom” and “socialism” were also popular, while topics such as Obamacare and immigration did not gain much traction.

Newswise: Americans continue struggling for a good night’s sleep during the pandemic
Released: 13-Apr-2021 9:00 AM EDT
Americans continue struggling for a good night’s sleep during the pandemic
American Academy of Sleep Medicine (AASM)

The coronavirus pandemic continues to have a negative impact on our sleep, according to new findings from the American Academy of Sleep Medicine.

Newswise:Video Embedded the-science-behind-the-shot-biotech-tools-developed-at-brookhaven-lab-fundamental-to-making-covid-19-vaccines
Released: 13-Apr-2021 8:05 AM EDT
The Science Behind the Shot: Biotech Tools Developed at Brookhaven Lab Fundamental to Making COVID-19 Vaccines
Brookhaven National Laboratory

You’ve probably heard that the first two vaccines approved for battling COVID-19 in the United States use a relatively new approach—injections of simple packets containing mRNA, a genetic material that instructs our cells to make coronavirus spike proteins. But the technology for generating sufficient amounts of those mRNA packets dates back to the 1980s, when F. William Studier, then a senior biophysicist at the U.S. Department of Energy’s Brookhaven National Laboratory, developed a way to harness the molecular machinery of a very different virus.

Newswise: UCLA Fielding School of Public Health Scholar’s Work on Fatigue and Health Published
Released: 13-Apr-2021 4:05 AM EDT
UCLA Fielding School of Public Health Scholar’s Work on Fatigue and Health Published
UCLA Fielding School of Public Health

A landmark work has been published examining fatigue as a hugely important factor in human health and extremely relevant to those with “long-haul” COVID-19 symptoms.

access_time Embargo lifts in 2 days
Embargo will expire: 14-Apr-2021 2:00 PM EDT Released to reporters: 12-Apr-2021 4:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Apr-2021 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Showing results

110 of 5391